Please login to the form below

Not currently logged in
Email:
Password:

Voyager Therapeutics appoints Matthew Ottmer as chief operating officer

He joins the gene therapy group from Momenta Pharmaceuticals

Matthew OttmerGene therapy focused group Voyager Therapeutics has appointed Matthew Ottmer as its new chief operating officer.

Ottmer has 18 years’ experience in biotechnology, including leadership of business operations, product development, and commercialisation across multiple therapeutic areas.

He said: “I am thrilled to join Voyager at this important time during the company’s evolution.

“Developing and implementing the initial commercial strategy and planning for VY-AADC for Parkinson’s disease is a top priority, especially as we approach the start of the pivotal programme, and I look forward to helping advance our exciting pipeline programmes as well.”

He joins Voyager most recently from Momenta Pharmaceuticals, where he was chief operating officer, responsible for programme and alliance management, research, clinical development, pharmaceutical sciences and commercial activities since late 2015.

Prior to Momenta, Ottmer spent 16 years at Biogen in a variety of leadership roles including senior vice president, strategy and emerging businesses, head of Tysabri business, chief of staff to the chief executive officer and president of Syntonix Pharmaceuticals - a wholly owned subsidiary of Biogen, now Bioverativ - and vice president of global operations.

Steven Paul, president and chief executive officer at Voyager, said: “AS Voyager’s business continues to expand, the fast pace and complexity of our expansion requires additional strong, cross-functional leadership that Matt has demonstrated throughout his career.

“In addition to leading strategy, programme and alliance management, Matt will oversee the commercial development plans of our lead and pipeline programmes.

“We are very excited to welcome Matt to our talented executive leadership team.”

2nd October 2017

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....

Infographics